Offer Documents
Important Information
Owing to restrictions imposed by law on soliciting securities business in various jurisdictions, the information in this section is directed at, and is intended for distribution to, and use by, residents of India only.
The information is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where (a) distribution or use of such information would be contrary to law or regulation; or (b) Jefferies India Private Limited would by virtue of such distribution become subject to new or additional registration or compliance requirements.
NOTHING IN THE DRHP CONSTITUTES AN OFFER OR AN INVITATION BY OR ON BEHALF OF EITHER THE ISSUER OF THE SECURITIES OR ANY OF THE MEMBERS OF THE SYNDICATE TO SUBSCRIBE FOR OR PURCHASE ANY OF THE SECURITIES DESCRIBED THEREIN. THE DRHP IS NOT A PROSPECTUS IN TERMS OF THE COMPANIES ACT, 2013. FURTHER, NOTHING HEREIN CONSTITUTES AN OFFER OR SOLICITATION OF SECURITIES FOR SALE IN THE UNITED STATES OR TO ANY U.S. PERSON (AS DEFINED BELOW) OR ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO DO SO. THIS DOCUMENT IS ONLY AVAILABLE TO RESIDENTS OF INDIA. YOU HAVE ACCESSED THE ATTACHED DOCUMENT(S) ON THE BASIS THAT YOU HAVE CONFIRMED TO JEFFERIES INDIA PRIVATE LIMITED THAT YOU ARE NOT RESIDENT IN THE UNITED STATES NOR A U.S. PERSON, AS DEFINED IN REGULATION S UNDER THE U.S. SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), NOR ACTING FOR THE BENEFIT OR ACCOUNT OF A U.S. PERSON. THE SECURITIES HAVE NOT BEEN AND WILL NOT BE REGISTERED UNDER THE SECURITIES ACT, OR THE SECURITIES LAWS OF ANY STATE OF THE UNITED STATES OR ANY OTHER JURISDICTION’S SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED OR SOLD IN THE UNITED STATES OR TO, OR FOR THE ACCOUNT OR BENEFIT OF, ANY U.S. PERSON ABSENT REGISTRATION UNDER THE U.S. SECURITIES LAWS OR UNLESS EXEMPT FROM REGISTRATION UNDER SUCH LAWS.
Filter By:
-
Letter of Offer
January 4, 2024
Grasim Industries LimitedGrasim Industries Limited – Letter of Offer
Offer Documents-Prospectus Country
Please select the country in which you are presently located:
I confirm that I am presently located in the selected jurisdiction.
Thank you for your interest
Unfortunately legal restrictions prevent us from allowing you further access to this website.
If you believe you are a resident of, and located in, a jurisdiction or jurisdictions where viewing is permitted by law, and you can confirm these points to us, please contact [email protected]
Acknowledgement
IMPORTANT: You must read and agree with the terms and conditions of the following disclaimer before continuing.
The following disclaimer applies to the letter of offer of Grasim Industries Limited (the “Company”) dated January 4, 2024 (the “Letter of Offer” / “LOF”) filed with Securities and Exchange Board of India (“SEBI”), BSE Limited and National Stock Exchange of India Limited (collectively, the “Stock Exchanges“) and hosted on this website in connection with the proposed rights issue of the Company (the “Rights Issue”) that Jefferies India Private Limited (“Jefferies”) is associated with as one of the Book Running Lead Managers. You are advised to read this disclaimer carefully before reading, accessing or making any other use of the LOF. By accessing the LOF, you agree to follow the following terms and conditions, including any modifications to them from time to time.
The contents of the LOF are for your information only. Further, no part of the contents herein shall be copied or duplicated in any form by any means or redistributed and in particular, may not be forwarded to any U.S. persons (as defined in Regulation S of the United States Securities Act of 1933, as amended (the “Securities Act”)) or to any U.S. address. Any forwarding, distribution or reproduction of the contents herein in whole or in part is unauthorized. Failure to comply with this directive may result in a violation of the Securities Act or the applicable laws of other jurisdictions. The Letter of Offer presented here in placed solely to comply with the provisions of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended (“SEBI ICDR Regulations”) and the Companies act, 2013, as amended (“Companies Act”). Neither Jefferies nor any of its Affiliates are soliciting any action based on any of the information contained on this website, including the LOF, and such information should not be construed as an offer, or invitation or offer to sell or the solicitation of any offer to buy or subscribe for or purchase any security. The LOF does not amount to a prospectus or a statement in lieu of prospectus in terms of the Companies Act, and nothing in the LOF constitutes an offer or an invitation by or on behalf of either the Company or any of the Book Running Lead Managers to subscribe for or purchase any of the securities described therein. The Letter of Offer has not been reviewed and approved by any regulatory authority in India or abroad, including the Securities and Exchange Board of India, any Registrar of Companies in India or any stock exchange in India. Neither Jefferies nor any of its affiliates or any of their respective directors, officers and employees (together, the “Affiliates”) represents that the contents of the LOF are accurate or complete. Jefferies nor any of its affiliates or any of their respective directors, officers and employees do not accept any liability whatsoever, direct or indirect, that may arise from the use of the information contained on this website. The information contained in the LOF may not be updated since its original publication date and may not reflect the latest updates, and neither Jefferies nor any of its Affiliates are under any obligation to update the LOF to reflect the latest circumstances arising after the date thereof.
Please note that because of restrictions imposed by applicable law or regulation on soliciting securities business in various jurisdictions, subscription to the Rights Issue will not be permitted to residents of certain jurisdictions. Accordingly, the Rights Issue related information on this site is not available to all jurisdictions. The LOF is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where (a) distribution or use of such information would not be permissible under or in violation of any applicable law or regulation; or (b) Jefferies or any of its Affiliates would by virtue of such distribution become subject to new or additional registration, licensing or other regulatory requirements.
The information contained in this portion of our website is directed at, and is intended for distribution to, and use by, residents of India only, and such information is not intended to be, and should not be, viewed by U.S. persons or any person in the United States. By accessing such information, you are hereby deemed to represent that (a) you are not a U.S. person and (b) you are not in the United States. The Rights Entitlements and the Rights Equity Shares have not been, and will not be, registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) and may not be offered or sold within the United States, except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the U.S. Securities Act and applicable state securities laws. Accordingly, the Rights Entitlements (including their credit) and the Rights Equity Shares are only being offered and sold outside the United States in “offshore transactions” as defined in and in reliance on Regulation S under the U.S. Securities Act to eligible equity shareholders located in jurisdictions where such offer and sale is permitted under the laws of such jurisdictions. This does not constitute, and should not be construed as, “general solicitation or general advertising” as defined under Regulation D of the Securities Act, or “directed selling efforts” under Regulation S of the Securities Act.
Any potential investor should note that investment in equity shares involves a high degree of risk. For details, potential investors should refer to the LOF filed by the Company with the SEBI and the Stock Exchanges, including the section titled “Risk Factors”. All terms not defined herein shall have the meanings ascribed to them in the LOF.
Jefferies, one of the Book Running Lead Managers has taken all necessary steps to ensure that the contents of the LOF as appearing on this website are identical to the LOF filed with the relevant regulatory authorities in India. However, you are reminded that documents transmitted in electronic form may be altered or changed during the process of transmission and consequently neither Jefferies nor any of its Affiliates, accept any liability or responsibility whatsoever in respect of alterations or changes which have taken place during the course of transmission of electronic data. Jefferies, its Affiliates and the Company will not be responsible for any loss or damage that could result from interception and interpretation by any third parties of any information being made available to you through this website.
Neither Jefferies and the Company, nor any of their affiliates nor their directors, officers and employees will be liable or have any responsibility of any kind for any loss or damage that you incur in the event of any failure or disruption of this website, or resulting from the act or omission of any other party involved in producing or hosting this website or the data contained therein available to you, or from any other cause relating to your access to, inability to access or use of the website or these materials.
Please note that forms downloaded and used for subscription to the Rights Issue in contravention of the above will be rejected with no recourse to Jefferies, any other Book Running Lead Manager to the Rights Issue, the Company, or any of their respective affiliates.
Overseas persons
Viewing this information may not be lawful in certain jurisdictions. In other jurisdictions, only certain categories of person may be allowed to view or use this information. Any person who wishes to view this site must first satisfy themselves that they are not subject to any local requirements which prohibit or restrict them from doing so. Please note that because of restrictions imposed by law on soliciting securities business in various jurisdictions, subscription to the Rights Issue will not be permitted to residents of certain jurisdictions. The LOF is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where (a) distribution or use of such information would be contrary to law or regulation; or (b) Jefferies or any of its Affiliates would by virtue of such distribution become subject to new or additional registration requirements.
If you are not permitted to view materials on this website or are in any doubt as to whether you are permitted to view these materials, please exit this webpage.
-
DRHP
December 28, 2023
Waaree Energies LimitedWaaree Energies Limited – DRHP
Offer Documents-Prospectus Country
Please select the country in which you are presently located:
I confirm that I am presently located in the selected jurisdiction.
Thank you for your interest
Unfortunately legal restrictions prevent us from allowing you further access to this website.
If you believe you are a resident of, and located in, a jurisdiction or jurisdictions where viewing is permitted by law, and you can confirm these points to us, please contact [email protected]
Acknowledgement
IMPORTANT: You must read and agree with the terms and conditions of the following disclaimer before continuing.
The following disclaimer applies to the draft red herring prospectus of Waaree Energies Limited (the “Company”) dated December 28, 2023 (the “Draft Red Herring Prospectus” / “DRHP”) filed with Securities and Exchange Board of India (“SEBI”) and hosted on this website in connection with the proposed initial public offering of equity shares of the Company (the “Offer”) that Jefferies India Private Limited (“Jefferies”) is associated with as one of the Book Running Lead Managers. The DRHP has been made available on this website in electronic form solely to comply with Regulation 26(1) of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended. You are advised to read this disclaimer carefully before reading, accessing or making any other use of the DRHP. By accessing the DRHP, you agree to follow the following terms and conditions, including any modifications to them from time to time.
The contents of the DRHP are for your information only. Further, no part of the contents herein shall be copied or duplicated in any form by any means or redistributed and in particular, may not be forwarded to any U.S. persons (as defined in Regulation S of the United States Securities Act of 1933, as amended (the “Securities Act”)) or to any U.S. address. Any forwarding, distribution or reproduction of the contents herein in whole or in part is unauthorized. Failure to comply with this directive may result in a violation of the Securities Act or the applicable laws of other jurisdictions. Neither Jefferies nor any of its Affiliates are soliciting any action based on any of the information contained on this website, including the DRHP, and such information should not be construed as an offer, or invitation or offer to sell or the solicitation of any offer to buy or subscribe for or purchase any security. The DRHP does not amount to a prospectus in terms of the Companies Act, 2013, and nothing in the DRHP constitutes an offer or an invitation by or on behalf of either the Company, the selling shareholders or any of the members of the syndicate to subscribe for or purchase any of the securities described therein. Neither Jefferies nor any of its affiliates or any of their respective directors, officers and employees (together, the “Affiliates”) represents that the contents of the DRHP are accurate or complete. The information contained in the DRHP may not be updated since its original publication date and may not reflect the latest updates, and neither Jefferies nor any of its Affiliates are under any obligation to update the DRHP to reflect the latest circumstances arising after the date hereof.
Please note that because of restrictions imposed by applicable law or regulation on soliciting securities business in various jurisdictions, subscription to the Offer will not be permitted to residents of certain jurisdictions. Accordingly, the Offer related information on this site is not available to all jurisdictions. The DRHP is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where (a) distribution or use of such information would not be permissible under or in violation of any applicable law or regulation; or (b) Jefferies or any of its Affiliates would by virtue of such distribution become subject to new or additional registration, licensing or other regulatory requirements.
The information contained in this portion of our website is directed at, and is intended for distribution to, and use by, residents of India only, and such information is not intended to be, and should not be, viewed by U.S. persons or any person in the United States. By accessing such information, you are hereby deemed to represent that (a) you are not a U.S. person and (b) you are not in the United States. The Equity Shares offered in the Offer have not been and will not be registered under the U.S. Securities Act of 1933, as amended or any state securities laws in the United States, and unless so registered may not be offered or sold within the United States, except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the U.S. Securities Act and applicable state securities laws. Accordingly, such Equity Shares are being offered and sold (i) outside the United States in offshore transactions in reliance on Regulation S under the U.S. Securities Act and the applicable laws of the jurisdiction where those offers and sales occur; and (ii) within the United States to “qualified institutional buyers” (as defined in Rule 144A under the U.S. Securities Act), pursuant to the private placement exemption set out in Section 4 of the U.S. Securities Act. This does not constitute, and should not be construed as, “general solicitation or general advertising” as defined under Regulation D of the Securities Act, or “directed selling efforts” under Regulation S of the Securities Act.
Any potential investor should note that investment in equity shares involves a high degree of risk. For details, potential investors should refer to the red herring prospectus, which may be filed by the Company with the Registrar of Companies, Maharashtra at Mumbai (“RoC”) in the future, including the section titled “Risk Factors”. Any decision on whether to invest in the equity shares described in the DRHP may only be made after a red herring prospectus has been filed with the RoC and with the SEBI, and must be made solely on the basis of such red herring prospectus. As there may be material changes in the red herring prospectus versus the DRHP.
Potential investors should not rely on the DRHP filed with SEBI.
Jefferies, one of the Book Running Lead Managers has taken all necessary steps to ensure that the contents of the DRHP as appearing on this website are identical to the DRHP filed with the relevant regulatory authorities in India. However, you are reminded that documents transmitted in electronic form may be altered or changed during the process of transmission and consequently neither Jefferies nor any of its Affiliates, accept any liability or responsibility whatsoever in respect of alterations or changes which have taken place during the course of transmission of electronic data. Jefferies, its Affiliates, the Company and the selling shareholders will not be responsible for any loss or damage that could result from interception and interpretation by any third parties of any information being made available to you through this website.
Neither Jefferies, the Company and selling shareholders, nor any of their affiliates nor their directors, officers and employees will be liable or have any responsibility of any kind for any loss or damage that you incur in the event of any failure or disruption of this website, or resulting from the act or omission of any other party involved in producing or hosting this website or the data contained therein available to you, or from any other cause relating to your access to, inability to access or use of the website or these materials.
Please note that forms downloaded and used for subscription to the Offer in contravention of the above will be rejected with no recourse to Jefferies, any other Book Running Lead Manager to the Offer, the Company, the selling shareholders or any of their respective affiliates.
Overseas persons
Viewing this information may not be lawful in certain jurisdictions. In other jurisdictions, only certain categories of person may be allowed to view or use this information. Any person who wishes to view this site must first satisfy themselves that they are not subject to any local requirements which prohibit or restrict them from doing so. Please note that because of restrictions imposed by law on soliciting securities business in various jurisdictions, subscription to the Offer will not be permitted to residents of certain jurisdictions. The DRHP is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where (a) distribution or use of such information would be contrary to law or regulation; or (b) Jefferies or any of its Affiliates would by virtue of such distribution become subject to new or additional registration requirements.
If you are not permitted to view materials on this website or are in any doubt as to whether you are permitted to view these materials, please exit this webpage.
-
DRHP
December 16, 2023
Emcure Pharma LimitedEmcure Pharma Limited – DRHP
Offer Documents-Prospectus Country
Please select the country in which you are presently located:
I confirm that I am presently located in the selected jurisdiction.
Thank you for your interest
Unfortunately legal restrictions prevent us from allowing you further access to this website.
If you believe you are a resident of, and located in, a jurisdiction or jurisdictions where viewing is permitted by law, and you can confirm these points to us, please contact [email protected]
Acknowledgement
IMPORTANT: You must read and agree with the terms and conditions of the following disclaimer before continuing.
THESE MATERIALS ARE NOT DIRECTED AT OR INTENDED TO BE ACCESSED BY PERSONS LOCATED OUTSIDE INDIA. THESE MATERIALS ARE BEING MADE AVAILABLE ON THIS WEBSITE TO COMPLY WITH SECURITIES AND EXCHANGE BOARD OF INDIA (ISSUE OF CAPITAL AND DISCLOSURE REQUIREMENTS) REGULATIONS, 2018, AS AMENDED.
Investors should read the Draft Red Herring Prospectus and seek professional advice before taking any action. Jefferies India Private Limited (“Jefferies”) does not accept any liability whatsoever direct or indirect that may arise from the use of the information contained in the Draft Red Herring Prospectus.
The following disclaimer applies to the Draft Red Herring Prospectus of Emcure Pharmaceuticals Limited (the “Company”) dated December 16, 2023 filed with the Securities and Exchange Board of India (“SEBI”) (the “Draft Red Herring Prospectus”) hosted on this website in connection with the public offering of securities (the “Offer”). Jefferies is associated with the Offer as a Book Running Lead Manager (“BRLM”). You are advised to read this disclaimer carefully before reading, accessing or making any other use of the Draft Red Herring Prospectus. By accessing the Draft Red Herring Prospectus, you agree to be bound by the following terms and conditions, including any modifications to them from time to time.
The Draft Red Herring Prospectus is directed at, and is intended for distribution to, and use by, residents of India only. Residents of countries other than India are not authorized to view or use the information in this portion of our website. The information in this portion of our website, including the Draft Red Herring Prospectus, is not for publication or distribution, directly or indirectly, in or into the United States. Please note that because of restrictions imposed by law on soliciting offers of securities in various jurisdictions, subscription to the Offer will not be permitted to residents of certain jurisdictions. The contents of the Draft Red Herring Prospectus are for your information only and you acknowledge that access to the Draft Red Herring Prospectus is intended for use by you only and you agree not to forward the Draft Red Herring Prospectus on to any other person, internal or external to your company, in whole or in part, or otherwise provide access via e-mail or otherwise to any person. No part of the contents of the Draft Red Herring Prospectus shall be copied or duplicated in any form by any means, or redistributed.
You are reminded that documents transmitted in electronic form may be altered or changed during the process of transmission and consequently neither Jefferies nor any of its affiliates, or their respective directors, officers and employees (together, the “Affiliates“), accepts any liability or responsibility whatsoever in respect of alterations or changes which have taken place during the course of transmission of electronic data.
The Draft Red Herring Prospectus does not constitute an offer to sell or an invitation to subscribe to the securities offered in any jurisdiction to any person and is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where (a) distribution or use of such information would be contrary to law or regulation; or (b) Jefferies or any of its Affiliates would by virtue of such distribution become subject to new or additional registration, licensing or other regulatory requirements.
The equity shares of the Company (the “Equity Shares”) have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) or any other applicable law of the United States and, unless so registered, may not be offered or sold within the United States absent registration under the U.S. Securities Act or except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the U.S. Securities Act and applicable state securities laws. Accordingly, the Equity Shares are being offered and sold (a) in the United States only to persons reasonably believed to be “qualified institutional buyers” (as defined in Rule 144A under the U.S. Securities Act) pursuant to Section 4(a) of the U.S. Securities Act, and (b) outside the United States in offshore transactions in compliance with Regulation S under the U.S. Securities Act and the applicable laws of the jurisdiction where those offers and sales are made. There will be no public offering of the Equity Shares in the United States.
Any person into whose possession the Draft Red Herring Prospectus comes is required to inform himself or herself about and to observe any such restrictions. Neither Jefferies nor any of its Affiliates is soliciting any action based on any information contained on this website, including the Draft Red Herring Prospectus, and such information should not be construed as an offer to sell or the solicitation of an offer to buy or subscribe for any securities. Potential investors should not rely on the Draft Red Herring Prospectus for any investment decision. Any decision on whether to invest in the securities described in the draft red herring prospectus may only be made after a red herring prospectus has been filed with the RoC and must be made solely on the basis of such red herring prospectus. As there may be material changes in the red herring prospectus as compared to the draft red herring prospectus, potential investors should not rely on the draft red herring prospectus. Any potential investor should note that investment in the securities involves a high degree of risk. For details, potential investors should refer to the Draft Red Herring Prospectus, which may be filed by the Company with the relevant Registrar of Companies, including the section titled “Risk Factors”.
Neither Jefferies nor any of its Affiliates will be responsible for any loss or damage that could result from interception and interpretation by any third parties of any information being made available to you through this website. Neither Jefferies nor any of its Affiliates represents that the content of the Draft Red Herring Prospectus is accurate or complete. Jefferies and its Affiliates cannot and do not guarantee the accuracy, timeliness or completeness of the information being made available to you in the Draft Red Herring Prospectus beyond the date of the Draft Red Herring Prospectus. The information contained in the Draft Red Herring Prospectus is as of the date thereof and neither Jefferies or its Affiliates are under any obligation to update the Draft Red Herring Prospectus to reflect circumstances arising after the date thereof.
Jefferies and its Affiliates will not be responsible for any loss to any person or entity caused by any shortcoming, defect or inaccuracy which may have inadvertently or otherwise crept into the website. Neither Jefferies, nor any of its Affiliates nor their directors, officers and employees will be liable or have any responsibility of any kind for any loss or damage that you incur in the event of any failure or disruption of this website, or resulting from the act or omission of any other party involved in making this website or the data contained therein available to you, or from any other cause relating to your access to, or inability to access or use of, the website or these materials.
Please note that forms downloaded and used for subscription to the Offer in contravention of the above will be rejected with no recourse to Jefferies, the Company, or any of their respective Affiliates.
If you are not permitted to view the materials on this website or are in any doubt as to whether you are permitted to view these materials, please exit this webpage.
-
DRHP
December 13, 2023
Entero Healthcare Solutions LimitedEntero Healthcare Solutions Limited – DRHP
Offer Documents-Prospectus Country
Please select the country in which you are presently located:
I confirm that I am presently located in the selected jurisdiction.
Thank you for your interest
Unfortunately legal restrictions prevent us from allowing you further access to this website.
If you believe you are a resident of, and located in, a jurisdiction or jurisdictions where viewing is permitted by law, and you can confirm these points to us, please contact [email protected]
Acknowledgement
IMPORTANT: You must read and agree with the terms and conditions of the following disclaimer before continuing.
THESE MATERIALS ARE NOT DIRECTED AT OR INTENDED TO BE ACCESSED BY PERSONS LOCATED OUTSIDE INDIA. THESE MATERIALS ARE BEING MADE AVAILABLE ON THIS WEBSITE TO COMPLY WITH SECURITIES AND EXCHANGE BOARD OF INDIA (ISSUE OF CAPITAL AND DISCLOSURE REQUIREMENTS) REGULATIONS, 2018, AS AMENDED.
Investors should read the Draft Red Herring Prospectus and seek professional advice before taking any action. Jefferies India Private Limited (“Jefferies”) does not accept any liability whatsoever direct or indirect that may arise from the use of the information contained in the Draft Red Herring Prospectus.
The following disclaimer applies to the Draft Red Herring Prospectus of Entero Healthcare Solutions Limited (the “Company”) dated September 13, 2023 filed with the Securities and Exchange Board of India (“SEBI”), BSE Limited (“BSE”) and National Stock Exchange of India Limited (“NSE”, and together with BSE, the “Stock Exchanges”) (the “Draft Red Herring Prospectus”) hosted on this website in connection with the public offering of securities (the “Offer”) that Jefferies is associated with as a Book Running Lead Manager (“BRLM”). You are advised to read this disclaimer carefully before reading, accessing or making any other use of the Draft Red Herring Prospectus. By accessing the Draft Red Herring Prospectus, you agree to be bound by the following terms and conditions, including any modifications to them from time to time.
The Draft Red Herring Prospectus is directed at, and is intended for distribution to, and use by, residents of India only. Residents of countries other than India are not authorized to view or use the information in this portion of our website. The information in this portion of our website, including the Draft Red Herring Prospectus, is not for publication or distribution, directly or indirectly, in or into the United States. Please note that because of restrictions imposed by law on soliciting securities business in various jurisdictions, subscription to the Offer will not be permitted to residents of certain jurisdictions. The contents of the Draft Red Herring Prospectus are for your information only and you acknowledge that access to the Draft Red Herring Prospectus is intended for use by you only and you agree not to forward the Draft Red Herring Prospectus on to any other person, internal or external to your company, in whole or in part, or otherwise provide access via e-mail or otherwise to any person. No part of the contents of the Draft Red Herring Prospectus shall be copied or duplicated in any form by any means, or redistributed.
The Draft Red Herring Prospectus has been made available on this website in electronic form solely to comply with the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended (the “SEBI ICDR Regulations”). Jefferies, as a BRLM, has taken all necessary steps to ensure that the contents of the Draft Red Herring Prospectus as appearing on this website are identical to the Draft Red Herring Prospectus filed with SEBI and the Stock Exchanges in accordance with the SEBI ICDR Regulations. You are reminded that documents transmitted in electronic form may be altered or changed during the process of transmission and consequently neither Jefferies nor any of its affiliates, or their respective directors, officers and employees (together, the “Affiliates“), accepts any liability or responsibility whatsoever in respect of alterations or changes which have taken place during the course of transmission of electronic data.
The Draft Red Herring Prospectus does not constitute an offer to sell or an invitation to subscribe to the securities offered in any jurisdiction to any person to whom it is unlawful to make an offer or invitation in such jurisdiction and is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where (a) distribution or use of such information would be contrary to law or regulation; or (b) Jefferies or any of its Affiliates would by virtue of such distribution become subject to new or additional registration, licensing or other regulatory requirements. The securities described in the Draft Red Herring Prospectus have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the “U.S. Securities Act”), or any state law of the United States and, unless so registered, may not be offered or sold within the United States, except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the U.S. Securities Act and applicable state securities laws.
Accordingly, the securities described in the Draft Red Herring Prospectus are being offered and sold (i) within the United States only to persons reasonably believed to be “qualified institutional buyers” (as defined in Rule 144A under the U.S. Securities Act) pursuant to Section 4(a) of the U.S. Securities Act, and (ii) outside the United States in “offshore transactions” as defined in and in compliance with Regulation S under the U.S. Securities Act and the applicable laws of the jurisdictions where those offers and sales are made. There will be no public offering of such securities in the United States.
Any person into whose possession the Draft Red Herring Prospectus comes is required to inform himself or herself about and to observe any such restrictions. Neither Jefferies nor any of its Affiliates is soliciting any action based on any information contained on this website, including the Draft Red Herring Prospectus, and such information should not be construed as an offer to sell or the solicitation of an offer to buy or subscribe for any securities. Potential investors should not rely on the Draft Red Herring Prospectus for any investment decision. Any decision on whether to invest in the securities described in the draft red herring prospectus may only be made after a red herring prospectus has been filed with the RoC and must be made solely on the basis of such red herring prospectus. As there may be material changes in the red herring prospectus as compared to the draft red herring prospectus, potential investors should not rely on the draft red herring prospectus. Any potential investor should note that investment in the securities involves a high degree of risk. For details, potential investors should refer to the red herring prospectus, including the section titled “Risk Factors”, when available.
Neither Jefferies nor any of its Affiliates will be responsible for any loss or damage that could result from interception and interpretation by any third parties of any information being made available to you through this website. Neither Jefferies nor any of its Affiliates represents that the content of the Draft Red Herring Prospectus is accurate or complete. Jefferies and its Affiliates cannot and do not guarantee the accuracy, timeliness or completeness of the information being made available to you in the Draft Red Herring Prospectus beyond the date of the Draft Red Herring Prospectus. The information contained in the Draft Red Herring Prospectus is as of the date thereof and neither Jefferies or its Affiliates are under any obligation to update the Draft Red Herring Prospectus to reflect circumstances arising after the date thereof.
Jefferies and its Affiliates will not be responsible for any loss to any person or entity caused by any shortcoming, defect or inaccuracy which may have inadvertently or otherwise crept into the website. Neither Jefferies, nor any of its Affiliates nor their directors, officers and employees will be liable or have any responsibility of any kind for any loss or damage that you incur in the event of any failure or disruption of this website, or resulting from the act or omission of any other party involved in making this website or the data contained therein available to you, or from any other cause relating to your access to, or inability to access or use of, the website or these materials.
Please note that forms downloaded and used for subscription to the Offer in contravention of the above will be rejected with no recourse to Jefferies, the Company, or any of their respective Affiliates.
If you are not permitted to view the materials on this website or are in any doubt as to whether you are permitted to view these materials, please exit this webpage.
-
DRHP
November 8, 2023
TBO Tek LimitedTBO Tek Limited – DRHP
Offer Documents-Prospectus Country
Please select the country in which you are presently located:
I confirm that I am presently located in the selected jurisdiction.
Thank you for your interest
Unfortunately legal restrictions prevent us from allowing you further access to this website.
If you believe you are a resident of, and located in, a jurisdiction or jurisdictions where viewing is permitted by law, and you can confirm these points to us, please contact [email protected]
Acknowledgement
IMPORTANT: You must read and agree with the terms and conditions of the following disclaimer before continuing.
The following disclaimer applies to the draft red herring prospectus of TBO Tek Limited (the “Company”) dated November 8, 2023 (the “DRHP”) filed with Securities and Exchange Board of India (“SEBI”) and hosted on this website in connection with the proposed initial public offering of equity shares of the Company (the “Offer”) that Jefferies India Private Limited (“Jefferies”) is associated with as one of the Book Running Lead Managers. The DRHP has been made available on this website in electronic form solely to comply with Regulation 26(1) of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended. You are advised to read this disclaimer carefully before reading, accessing or making any other use of the DRHP. By accessing the DRHP, you agree to follow the following terms and conditions, including any modifications to them from time to time.
The contents of the DRHP are for your information only. Further, no part of the contents herein shall be copied or duplicated in any form by any means or redistributed and in particular, may not be forwarded to any U.S. persons (as defined in Regulation S of the United States Securities Act of 1933, as amended (the “Securities Act”)) or to any U.S. address. Any forwarding, distribution or reproduction of the contents herein in whole or in part is unauthorized. Failure to comply with this directive may result in a violation of the Securities Act or the applicable laws of other jurisdictions. Neither Jefferies nor any of its Affiliates are soliciting any action based on any of the information contained on this website, including the DRHP, and such information should not be construed as an offer, or invitation or offer to sell or the solicitation of any offer to buy or subscribe for or purchase any security. The DRHP does not amount to a prospectus in terms of the Companies Act, 2013, and nothing in the DRHP constitutes an offer or an invitation by or on behalf of either the Company, the selling shareholders or any of the members of the syndicate to subscribe for or purchase any of the securities described therein. Neither Jefferies nor any of its affiliates or any of their respective directors, officers and employees (together, the “Affiliates”) represents that the contents of the DRHP are accurate or complete. The information contained in the DRHP may not be updated since its original publication date and may not reflect the latest updates, and neither Jefferies nor any of its Affiliates are under any obligation to update the DRHP to reflect the latest circumstances arising after the date hereof.
Please note that because of restrictions imposed by applicable law or regulation on soliciting securities business in various jurisdictions, subscription to the Offer will not be permitted to residents of certain jurisdictions. Accordingly, the Offer related information on this site is not available to all jurisdictions. The DRHP is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where (a) distribution or use of such information would not be permissible under or in violation of any applicable law or regulation; or (b) Jefferies or any of its Affiliates would by virtue of such distribution become subject to new or additional registration, licensing or other regulatory requirements.
The information contained in this portion of our website is directed at, and is intended for distribution to, and use by, residents of India only, and such information is not intended to be, and should not be, viewed by U.S. persons or any person in the United States. By accessing such information, you are hereby deemed to represent that (a) you are not a U.S. person and (b) you are not in the United States. The information contained in this website does not constitute an offer for sale in the United States. The securities described in the DRHP have not been, and will not be, registered under the Securities Act, or with any securities regulatory authority of any state or other jurisdiction in the United States and may not be offered or sold, directly or indirectly, into the United States unless the securities are so registered or an exemption from the registration requirements is available. This does not constitute, and should not be construed as, “general solicitation or general advertising” as defined under Regulation D of the Securities Act, or “directed selling efforts” under Regulation S of the Securities Act.
Any potential investor should note that investment in equity shares involves a high degree of risk. For details, potential investors should refer to the red herring prospectus, which may be filed by the Company with the Registrar of Companies, Delhi and Haryana at New Delhi (“RoC”) in the future, including the section titled “Risk Factors”. Any decision on whether to invest in the equity shares described in the DRHP may only be made after a red herring prospectus has been filed with the RoC and with the SEBI, and must be made solely on the basis of such red herring prospectus. As there may be material changes in the red herring prospectus versus the DRHP.
Potential investors should not rely on the DRHP filed with SEBI.
Jefferies, one of the Book Running Lead Managers has taken all necessary steps to ensure that the contents of the DRHP as appearing on this website are identical to the DRHP filed with the relevant regulatory authorities in India. However, you are reminded that documents transmitted in electronic form may be altered or changed during the process of transmission and consequently neither Jefferies nor any of its Affiliates, accept any liability or responsibility whatsoever in respect of alterations or changes which have taken place during the course of transmission of electronic data. Jefferies, its Affiliates, the Company and the selling shareholders will not be responsible for any loss or damage that could result from interception and interpretation by any third parties of any information being made available to you through this website.
Neither Jefferies, the Company and selling shareholders, nor any of their affiliates nor their directors, officers and employees will be liable or have any responsibility of any kind for any loss or damage that you incur in the event of any failure or disruption of this website, or resulting from the act or omission of any other party involved in producing or hosting this website or the data contained therein available to you, or from any other cause relating to your access to, inability to access or use of the website or these materials.
Please note that forms downloaded and used for subscription to the Offer in contravention of the above will be rejected with no recourse to Jefferies, any other Book Running Lead Manager to the Offer, the Company, the selling shareholders or any of their respective affiliates.
Overseas persons
Viewing this information may not be lawful in certain jurisdictions. In other jurisdictions, only certain categories of person may be allowed to view or use this information. Any person who wishes to view this site must first satisfy themselves that they are not subject to any local requirements which prohibit or restrict them from doing so. Please note that because of restrictions imposed by law on soliciting securities business in various jurisdictions, subscription to the Offer will not be permitted to residents of certain jurisdictions. The DRHP is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where (a) distribution or use of such information would be contrary to law or regulation; or (b) Jefferies or any of its Affiliates would by virtue of such distribution become subject to new or additional registration requirements.
If you are not permitted to view materials on this website or are in any doubt as to whether you are permitted to view these materials, please exit this webpage.
-
Prospectus
August 9, 2023
Concord Biotech LimitedConcord Biotech Limited – Prospectus
Offer Documents-Prospectus Country
Please select the country in which you are presently located:
I confirm that I am presently located in the selected jurisdiction.
Thank you for your interest
Unfortunately legal restrictions prevent us from allowing you further access to this website.
If you believe you are a resident of, and located in, a jurisdiction or jurisdictions where viewing is permitted by law, and you can confirm these points to us, please contact [email protected]
Acknowledgement
IMPORTANT: You must read and agree with the terms and conditions of the following disclaimer before continuing.
THESE MATERIALS ARE NOT DIRECTED AT OR INTENDED TO BE ACCESSED BY PERSONS LOCATED OUTSIDE INDIA. THESE MATERIALS ARE BEING MADE AVAILABLE ON THIS WEBSITE TO COMPLY WITH SECURITIES AND EXCHANGE BOARD OF INDIA (ISSUE OF CAPITAL AND DISCLOSURE REQUIREMENTS) REGULATIONS, 2018, AS AMENDED.
The following disclaimer applies to the Prospectus of Concord Biotech Limited (the “Company”) dated August 9, 2023 (the “Prospectus”) filed with the Registrar of Companies, Gujarat at Ahmedabad (“RoC”) and the Securities and Exchange Board of India (“SEBI”) and hosted on this website. In accessing the Prospectus, you agree to be bound by the following terms and conditions, including any modifications to them from time to time.
The Prospectus is directed at, and is intended for distribution to, and use by, residents of India only. The information in this portion of our website, including the Prospectus, is not for publication or distribution, directly or indirectly, in or into the United States. No part of the contents of the Prospectus shall be copied or duplicated in any form by any means, or redistributed.
Jefferies India Private Limited (“Jefferies”), as one of the Book Running Lead Managers to the offering, has taken all necessary steps to ensure that the contents of the Prospectus as appearing on this website are identical to the Prospectus filed with the RoC and the SEBI. You are reminded that documents transmitted in electronic form may be altered or changed during the process of transmission and consequently, neither Jefferies nor any of its affiliates accepts any liability or responsibility whatsoever in respect of alterations or changes which have taken place during the course of transmission of electronic data.
The Prospectus does not constitute an offer to sell or an invitation to subscribe to the securities offered in any jurisdiction to any person to whom it is unlawful to make an offer or invitation in such jurisdiction and is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where (a) distribution or use of such information would be contrary to law or regulation; or (b) Jefferies or any of its affiliates would by virtue of such distribution become subject to new or additional registration, licensing or other regulatory requirements. The Equity Shares offered in the Offer have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the “U.S. Securities Act”) or any state securities laws in the United States, and unless so registered may not be offered or sold within the United States, except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the U.S. Securities Act and applicable state securities laws. Accordingly, such Equity Shares are being offered and sold (i) outside of the United States in “offshore transactions” as defined in and in compliance with Regulation S under the U.S. Securities Act and the applicable laws of the jurisdiction where those offers and sales occur; and (ii) to “qualified institutional buyers” (as defined in Rule 144A under the U.S. Securities Act) under Section 4(a) of the U.S. Securities Act.
Any person into whose possession the Prospectus comes is required to inform himself or herself about and to observe any such restrictions. Neither Jefferies, nor any of its affiliates is soliciting any action based on the Draft Red Herring Prospectus dated August 12, 2022 (“Draft Red Herring Prospectus”), and it should not be construed as an offer to sell or the solicitation of an offer to buy any securities. Potential investors should not rely on the Draft Red Herring Prospectus for any investment decision. Any potential investor should note that investment in equity shares involves a high degree of risk and for details relating to such risk, see “Risk Factors” in the Prospectus.
Neither Jefferies nor any of its affiliates will be responsible for any loss or damage that could result from interception and interpretation by any third parties of any information being made available to you through this website. Jefferies and its affiliates cannot and do not guarantee the accuracy, timeliness or completeness of the information being made available to you in the Prospectus beyond the date of the Prospectus. Jefferies and its affiliates will not be responsible for any loss to any person or entity caused by any shortcoming, defect or inaccuracy which may have inadvertently or otherwise crept into the website. Neither Jefferies, nor any of its affiliates nor their directors, officers and employees, will be liable or have any responsibility of any kind for any loss or damage that you incur in the event of any failure or disruption of this website, or resulting from the act or omission of any other party involved in making this website or the data contained therein available to you, or from any other cause relating to your access to, inability to access, or use of the website or these materials.
If you are not permitted to view the materials on this website or are in any doubt as to whether you are permitted to view these materials, please exit this webpage.
-
RHP
July 27, 2023
Concord Biotech LimitedConcord Biotech Limited – RHP
Offer Documents-Prospectus Country
Please select the country in which you are presently located:
I confirm that I am presently located in the selected jurisdiction.
Thank you for your interest
Unfortunately legal restrictions prevent us from allowing you further access to this website.
If you believe you are a resident of, and located in, a jurisdiction or jurisdictions where viewing is permitted by law, and you can confirm these points to us, please contact [email protected]
Acknowledgement
IMPORTANT: You must read and agree with the terms and conditions of the following disclaimer before continuing.
The following disclaimer applies to the draft red herring prospectus of Gold Plus Glass Industry Limited (the “Company”) dated April 8, 2022 (the “DRHP”) filed with Securities and Exchange Board of India (“SEBI”) and hosted on this website in connection with the proposed initial public offering of equity shares of the Company (the “Offer”) that Jefferies India Private Limited is associated with as one of the Book Running Lead Managers. The DRHP has been made available on this website in electronic form solely to comply with Regulation 26(1) of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended. You are advised to read this disclaimer carefully before reading, accessing or making any other use of the DRHP. By accessing the DRHP, you agree to follow the following terms and conditions, including any modifications to them from time to time.
The contents of the DRHP are for your information only. No part of the contents herein shall be copied or duplicated in any form by any means or redistributed and in particular, may not be forwarded to any U.S. persons (as defined in Regulation S of the United States Securities Act of 1933, as amended (the “Securities Act”)) or to any U.S. address. Any forwarding, distribution or reproduction of the contents herein in whole or in part is unauthorized. Failure to comply with this directive may result in a violation of the Securities Act or the applicable laws of other jurisdictions. Neither Jefferies India Private Limited nor any of its affiliates are soliciting any action based on any of the information contained on this website, including the DRHP, and such information should not be construed as an offer, or invitation or offer to sell or the solicitation of any offer to buy or subscribe for or purchase any security. The DRHP does not amount to a prospectus in terms of the Companies Act, 2013, and nothing in the DRHP constitutes an offer or an invitation by or on behalf of either the Company or any of the members of the syndicate to subscribe for or purchase any of the securities described therein. Neither Jefferies India Private Limited nor any of its affiliates represents that the contents of the DRHP are accurate or complete. The information contained in the DRHP may not be updated since its original publication date and may not reflect the latest updates.
Please note that because of restrictions imposed by applicable law or regulation on soliciting securities business in various jurisdictions, subscription to the Offer will not be permitted to residents of certain jurisdictions. Accordingly, the Offer related information on this site is not available to all jurisdictions. The DRHP is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where (a) distribution or use of such information would not be permissible under or in violation of any applicable law or regulation; or (b) Jefferies India Private Limited or any of its affiliates would by virtue of such distribution become subject to new or additional registration, licensing or other regulatory requirements.
The information contained in this portion of our website is not intended to be, and should not be, viewed by U.S. persons or any person in the United States. By accessing such information, you are hereby deemed to represent that (a) you are not a U.S. person and (b) you are not in the United States. The information contained in this website does not constitute an offer for sale in the United States. The securities described in the DRHP have not been, and will not be, registered under the Securities Act, or with any securities regulatory authority of any state or other jurisdiction in the United States and may not be offered or sold, directly or indirectly, into the United States unless the securities are so registered or an exemption from the registration requirements is available. This does not constitute, and should not be construed as, “general solicitation or general advertising” as defined under Regulation D of the Securities Act, or “directed selling efforts” under Regulation S of the Securities Act.
Any potential investor should note that investment in equity shares involves a high degree of risk. For details, potential investors should refer to the red herring prospectus, which may be filed with the Registrar of Companies, National Capital Territory of Delhi and Haryana at New Delhi (“RoC”) in the future, including the section titled “Risk Factors”. Any decision on whether to invest in the equity shares described in the DRHP may only be made after a red herring prospectus has been filed with the SEBI and the RoC, and must be made solely on the basis of such red herring prospectus. As there may be material changes in the red herring prospectus versus the DRHP, potential investors should not rely on the DRHP filed with SEBI.
Jefferies India Private Limited, one of the Book Running Lead Managers has taken all necessary steps to ensure that the contents of the DRHP as appearing on this website are identical to the DRHP filed with the relevant regulatory authorities in India. However, you are reminded that documents transmitted in electronic form may be altered or changed during the process of transmission and consequently neither Jefferies India Private Limited nor any of its affiliates, nor any of their respective directors, officers and employees, accept any liability or responsibility whatsoever in respect of alterations or changes which have taken place during the course of transmission of electronic data. Jefferies India Private Limited, its affiliates, the Company will not be responsible for any loss or damage that could result from interception and interpretation by any third parties of any information being made available to you through this website.
Neither Jefferies India Private Limited, Company nor any of their affiliates nor their directors, officers and employees will be liable or have any responsibility of any kind for any loss or damage that you incur in the event of any failure or disruption of this website, or resulting from the act or omission of any other party involved in producing or hosting this website or the data contained therein available to you, or from any other cause relating to your access to, inability to access or use of the website or these materials.
Please note that forms downloaded and used for subscription to the Offer in contravention of the above will be rejected with no recourse to Jefferies India Private Limited, any other Book Running Lead Manager to the Offer, the Company, or any of their respective affiliates.
Overseas persons
Viewing this information may not be lawful in certain jurisdictions. In other jurisdictions, only certain categories of person may be allowed to view or use this information. Any person who wishes to view this site must first satisfy themselves that they are not subject to any local requirements which prohibit or restrict them from doing so. Please note that because of restrictions imposed by law on soliciting securities business in various jurisdictions, subscription to the Offer will not be permitted to residents of certain jurisdictions. The DRHP is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where (a) distribution or use of such information would be contrary to law or regulation; or (b) Jefferies India Private Limited or any of its affiliates would by virtue of such distribution become subject to new or additional registration requirements.
If you are not permitted to view materials on this website or are in any doubt as to whether you are permitted to view these materials, please exit this webpage.
-
Prospectus
April 28, 2023
Mankind Pharma LimitedMankind Pharma Limited – Prospectus
Offer Documents-Prospectus Country
Please select the country in which you are presently located:
I confirm that I am presently located in the selected jurisdiction.
Thank you for your interest
Unfortunately legal restrictions prevent us from allowing you further access to this website.
If you believe you are a resident of, and located in, a jurisdiction or jurisdictions where viewing is permitted by law, and you can confirm these points to us, please contact [email protected]
Acknowledgement
IMPORTANT: You must read and agree with the terms and conditions of the following disclaimer before continuing.
THESE MATERIALS ARE NOT DIRECTED AT OR INTENDED TO BE ACCESSED BY PERSONS LOCATED OUTSIDE INDIA. THESE MATERIALS ARE BEING MADE AVAILABLE ON THIS WEBSITE TO COMPLY WITH SECURITIES AND EXCHANGE BOARD OF INDIA (ISSUE OF CAPITAL AND DISCLOSURE REQUIREMENTS) REGULATIONS, 2018, AS AMENDED.
The following disclaimer applies to the Prospectus of Mankind Pharma Limited (the “Company”) dated April 28, 2023 (the “Prospectus”) filed with the Registrar of Companies, Delhi and Haryana at New Delhi (“RoC”), the Securities and Exchange Board of India (“SEBI”), BSE Limited (“BSE”), and the National Stock Exchange of India Limited (“NSE”) and hosted on this website. In accessing the Prospectus, you agree to be bound by the following terms and conditions, including any modifications to them from time to time. You are advised to read this disclaimer carefully before reading, accessing or making any other use of the Prospectus.
The Prospectus is directed at, and is intended for distribution to, and use by, residents of India only. The information in this portion of our website, including the Prospectus, is not for publication or distribution, directly or indirectly, in or into the United States. No part of the contents of the Prospectus shall be copied or duplicated in any form by any means, or redistributed.
The Prospectus has been hosted on this website as prescribed under Regulation 26(1) of the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended (the “SEBI ICDR Regulations”). Jefferies India Private Limited (“Jefferies”), as one of the Book Running Lead Managers to the offering has taken all necessary steps to ensure that the contents of the Prospectus as appearing on this website are identical to the Prospectus filed with the RoC, SEBI, BSE, and NSE. You are reminded that documents transmitted in electronic form may be altered or changed during the process of transmission and consequently, neither Jefferies India Private Limited nor any of its affiliates accepts any liability or responsibility whatsoever in respect of alterations or changes which have taken place during the course of transmission of electronic data.
The Prospectus does not constitute an offer to sell or an invitation to subscribe to the securities offered in any jurisdiction to any person to whom it is unlawful to make an offer or invitation in such jurisdiction and is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where (a) distribution or use of such information would be contrary to law or regulation; or (b) Jefferies India Private Limited or any of its affiliates would by virtue of such distribution become subject to new or additional registration, licensing or other regulatory requirements. The Equity Shares offered in the Offer have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the “U.S. Securities Act”) or any state securities laws in the United States, and unless so registered may not be offered or sold within the United States, except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the U.S. Securities Act and applicable state securities laws. Accordingly, such Equity Shares are being offered and sold (i) outside of the United States in offshore transactions in reliance on Regulation S under the U.S. Securities Act and the applicable laws of the jurisdiction where those offers and sales occur; and (ii) to “qualified institutional buyers” (as defined in Rule 144A under the U.S. Securities Act), pursuant to Section 4(a) of the U.S. Securities Act.
Any person into whose possession the Prospectus comes is required to inform himself or herself about and to observe any such restrictions. Neither Jefferies India Private Limited, nor any of its affiliates is not soliciting any action based on the Prospectus, and it should not be construed as an offer to sell or the solicitation of an offer to buy any securities. Potential investors should not rely on the Prospectus for any investment decision. Any potential investor should note that investment in equity shares involves a high degree of risk and for details relating to such risk, see the section titled “Risk Factors” of the Prospectus.
Neither Jefferies India Private Limited nor any of its affiliates will be responsible for any loss or damage that could result from interception and interpretation by any third parties of any information being made available to you through this website. Jefferies India Private Limited and its affiliates cannot and do not guarantee the accuracy, timeliness or completeness of the information being made available to you in the Prospectus beyond the date of the Prospectus. The information contained in the Prospectus may not be updated since its original publication date, and may not reflect the latest updates. Jefferies India Private Limited and its affiliates will not be responsible for any loss to any person or entity caused by any shortcoming, defect or inaccuracy which may have inadvertently or otherwise crept into the website. Neither Jefferies India Private Limited, nor any of its affiliates nor their directors, officers and employees will be liable or have any responsibility of any kind for any loss or damage that you incur in the event of any failure or disruption of this website, or resulting from the act or omission of any other party involved in making this website or the data contained therein available to you, or from any other cause relating to your access to, inability to access, or use of the website or these materials.
If you are not permitted to view the materials on this website or are in any doubt as to whether you are permitted to view these materials, please exit this webpage.
-
RHP
April 14, 2023
Mankind Pharma LimitedMankind Pharma Limited – RHP
Offer Documents-Prospectus Country
Please select the country in which you are presently located:
I confirm that I am presently located in the selected jurisdiction.
Thank you for your interest
Unfortunately legal restrictions prevent us from allowing you further access to this website.
If you believe you are a resident of, and located in, a jurisdiction or jurisdictions where viewing is permitted by law, and you can confirm these points to us, please contact [email protected]
Acknowledgement
IMPORTANT: You must read and agree with the terms and conditions of the following disclaimer before continuing.
THESE MATERIALS ARE NOT DIRECTED AT OR INTENDED TO BE ACCESSED BY PERSONS LOCATED OUTSIDE INDIA. THESE MATERIALS ARE BEING MADE AVAILABLE ON THIS WEBSITE TO COMPLY WITH SECURITIES AND EXCHANGE BOARD OF INDIA (ISSUE OF CAPITAL AND DISCLOSURE REQUIREMENTS) REGULATIONS, 2018, AS AMENDED.
The following disclaimer applies to the Red Herring Prospectus of Mankind Pharma Limited (the “Company”) dated April 14, 2023 (the “Red Herring Prospectus”) filed with the Securities and Exchange Board of India (“SEBI”) on April 14, 2023 and hosted on this website. In accessing the Red Herring Prospectus, you agree to be bound by the following terms and conditions, including any modifications to them from time to time. You are advised to read this disclaimer carefully before reading, accessing or making any other use of the Red Herring Prospectus.
The Red Herring Prospectus is directed at, and is intended for distribution to, and use by, residents of India only. The information in this portion of our website, including the Red Herring Prospectus, is not for publication or distribution, directly or indirectly, in or into the United States. No part of the contents of the Red Herring Prospectus shall be copied or duplicated in any form by any means, or redistributed.
The Red Herring Prospectus has been hosted on this website as prescribed under Regulation 26(1) of the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended (the “SEBI ICDR Regulations”). Jefferies India Private Limited (“Jefferies”), as one of the Book Running Lead Managers to the offering has taken all necessary steps to ensure that the contents of the Red Herring Prospectus as appearing on this website are identical to the Red Herring Prospectus filed with the SEBI. You are reminded that documents transmitted in electronic form may be altered or changed during the process of transmission and consequently, neither Jefferies India Private Limited nor any of its affiliates accepts any liability or responsibility whatsoever in respect of alterations or changes which have taken place during the course of transmission of electronic data.
The Red Herring Prospectus does not constitute an offer to sell or an invitation to subscribe to the securities offered in any jurisdiction to any person to whom it is unlawful to make an offer or invitation in such jurisdiction and is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where (a) distribution or use of such information would be contrary to law or regulation; or (b) Jefferies India Private Limited or any of its affiliates would by virtue of such distribution become subject to new or additional registration, licensing or other regulatory requirements. The Equity Shares offered in the Offer have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the “U.S. Securities Act”) or any state securities laws in the United States, and unless so registered may not be offered or sold within the United States, except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the U.S. Securities Act and applicable state securities laws. Accordingly, such Equity Shares are being offered and sold (i) outside of the United States in offshore transactions in reliance on Regulation S under the U.S. Securities Act and the applicable laws of the jurisdiction where those offers and sales occur; and (ii) to “qualified institutional buyers” (as defined in Rule 144A under the U.S. Securities Act), pursuant to Section 4(a) of the U.S. Securities Act.
Any person into whose possession the Red Herring Prospectus comes is required to inform himself or herself about and to observe any such restrictions. Neither Jefferies India Private Limited, nor any of its affiliates is not soliciting any action based on the Red Herring Prospectus, and it should not be construed as an offer to sell or the solicitation of an offer to buy any securities. Potential investors should not rely on the Red Herring Prospectus for any investment decision. Any potential investor should note that investment in equity shares involves a high degree of risk and for details relating to such risk, see the section titled “Risk Factors” of the Red Herring Prospectus.
Neither Jefferies India Private Limited nor any of its affiliates will be responsible for any loss or damage that could result from interception and interpretation by any third parties of any information being made available to you through this website. [•] and its affiliates cannot and do not guarantee the accuracy, timeliness or completeness of the information being made available to you in the Red Herring Prospectus beyond the date of the Red Herring Prospectus. The information contained in the Red Herring Prospectus may not be updated since its original publication date, and may not reflect the latest updates. Jefferies India Private Limited and its affiliates will not be responsible for any loss to any person or entity caused by any shortcoming, defect or inaccuracy which may have inadvertently or otherwise crept into the website. Neither Jefferies India Private Limited, nor any of its affiliates nor their directors, officers and employees will be liable or have any responsibility of any kind for any loss or damage that you incur in the event of any failure or disruption of this website, or resulting from the act or omission of any other party involved in making this website or the data contained therein available to you, or from any other cause relating to your access to, inability to access, or use of the website or these materials.
If you are not permitted to view the materials on this website or are in any doubt as to whether you are permitted to view these materials, please exit this webpage.
Stay Current With Updates
Subscribe to our email for all our latest insights and timely content.